Glyxambi
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 3312
  • Home
  • Print this page
  • Email this page

   Table of Contents      
CASE REPORT
Year : 2019  |  Volume : 67  |  Issue : 11  |  Page : 1886-1888

18S rDNA sequencing aided diagnosis of Acanthamoeba jacobsi keratitis -A case report


1 Dr. Shroff's Charity Eye Hospital, New Delhi, India
2 Jhaveri Microbiology Centre, LV Prasad Eye Institute, Hyderabad, Telangana, India

Date of Submission06-Dec-2018
Date of Acceptance30-Jun-2019
Date of Web Publication22-Oct-2019

Correspondence Address:
Dr. Aastha Singh
Dr.Shroff's Charity Eye Hospital, 5027, Kedarnath Road, Daryaganj, New Delhi
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijo.IJO_2019_18

Rights and Permissions
  Abstract 


Identification of Acanthamoeba cysts and trophozoites in cases of keratitis is traditionally done with microbiological techniques such as smear examination with 10% potassium hydroxide (KOH) and culture. Double walled cyst with hexagonal inner wall is characteristic of Acanthamoeba. We report a unique case of a 9 year old boy who presented with dense anterior corneal stromal infltration, which on smear examination showed atypical double walled spherical cysts, leading to a diagnostic dilemma. An 18S rRNA gene-based PCR done on the growth on culture, subsequently identifed a rarely reported species of Acanthamoeba. The patient was advised combination therapy with polyhexamethylene biguanide (PHMB 0.02%) and chlorhexidine (0.02%) eye drops. Three weeks post treatment, the keratitis resolved with scarring and vascularisation and visual acuity improved to 20/60. At 8 weeks follow up Best corrected visual acuity further improved to 20/30 with contact lens.

Keywords: Acanthamoeba, gene sequencing, keratitis


How to cite this article:
Singh A, Acharya M, Jose N, Gandhi A, Sharma S. 18S rDNA sequencing aided diagnosis of Acanthamoeba jacobsi keratitis -A case report. Indian J Ophthalmol 2019;67:1886-8

How to cite this URL:
Singh A, Acharya M, Jose N, Gandhi A, Sharma S. 18S rDNA sequencing aided diagnosis of Acanthamoeba jacobsi keratitis -A case report. Indian J Ophthalmol [serial online] 2019 [cited 2019 Nov 15];67:1886-8. Available from: http://www.ijo.in/text.asp?2019/67/11/1886/269623



Acanthamoeba are parasites commonly present in the natural environment and are a frequent cause of keratitis.[1] The first case of Acanthamoeba keratitis was reported in a contact lens wearer in 1974.[2] The prevalence of Acanthamoeba keratitis (AK) ranges from 1 per 10,000 to 1,000,000 as per various studies.[3] The clinical presentation of Acanthamoeba keratitis is varied and microbiological analysis is a useful tool in definite identification of the organism. Traditional microbiological techniques to identify Acanthamoeba species in corneal scrapings comprise of 10% potassium hydroxide (KOH) mount which characteristically shows double walled cysts of Acanthamoeba with hexagonal inner wall, Gram's stain and culture on non-nutrient agar (NNA) with E. coli overlay. However, an 18S rDNA gene-based PCR test, highly specific for the genus Acanthamoeba, is a useful tool for molecular confirmation of Acanthamoeba keratitis as described by Schroeder et al.[4] We report a case of Acanthamoeba keratitis that showed atypical morphology of cysts in direct microscopy of the corneal scrapings and application of molecular test subsequently helped identify a rarely reported species of Acanthamoeba.


  Case Report Top


A 9-year-old male, resident of North India presented with complaints of diminution of vision, pain, photophobia, redness, and watering in the right eye since 3 months. There was no history of trauma or use of contact lenses. His Best Corrected Visual Acuity (BCVA) in the right eye was ability to perceive Hand Movements Close to Face (HMCF) and in the left eye was 20/20. On anterior segment examination, the upper palpebral conjunctiva in both eyes showed papillae with congestion. The cornea had dense anterior stromal infiltration with an epithelial defect (7 mm × 5 mm), surrounding stromal oedema and vascularization. [Figure 1]a Anterior chamber, lens, and fundus details were indiscernible in the right eye. B scan ultrasonography of the right eye revealed normal lens and posterior segment status. The left eye examination was essentially within normal limits.
Figure 1: Clinical picture (a) Day of presentation; dense anterior stromal infiltration with an epithelial defect and surrounding stromal oedema and vascularisation (b) status quo post 1 week of treatment with PHMB (0.02%) eyedrops (c) commencement of peripheral healing at 3 weeks post addition of chlorhexidine (0.02%) eyedrops (d) complete healing and vascularization of ulcer at 6 weeks post treatment with PHMB (0.02%) and chlorhexidine (0.02%) eyedrops

Click here to view


The patient was diagnosed as a case of microbial keratitis elsewhere and was on 4th generation fluoroquinolone and antifungal eyedrops on presentation to us since the past 8 weeks. Corneal scraping was done at our hospital which did not reveal any organism on microsopic smear examination with 10% potassium hydroxide (KOH), Gram, and Giemsa stains. The patient was then given a drug holiday where in only tear supplements, cycloplegic and bacteriostatic chloramphenicol (0.5%) eye drops four times a day were prescribed. Forty-eight hours post drug holiday, rescraping was done. Smear examination showed double-walled spherical cysts in KOH preparation and Gram's stain [Figure 2]. Although the cysts did not represent the typical hexagonal inner walled cysts of Acanthamoeba, a presumptive diagnosis of Acanthamoeba keratitiswas made based on clinical presentation. The patient was advised monotherapy with 0.02% polyhexamethylene biguanide (PHMB) eye drops hourly, 1% atropine eye drops 3 times a day and tear supplements 3 times a day. One week post treatment with PHMB (0.02%) eye drops, the patient did not show clinical improvement [Figure 1]b. Eyedrop chlorhexidine (0.02%) 1 hourly was then added to the treatment. Rescraping was done at this stage and smear examination again showed double-walled spherical cysts.
Figure 2: Microscopic features of Acanthamoeba cyst in corneal scraping — (a) KOH and (b) Gram's stain. Note: Double-walled spherical cysts

Click here to view


As the morphology of the cysts resembled cysts of Dictyostelium polycephalum reported in earlier case reports, additional corneal scrapings of the patient were sent to L. V. Prasad Eye Institute (LVPEI) for a PCR test.[5] Corneal scrapings inoculated on non-nutrient agar plate with E. coli overlay were also sent. DNA was extracted from the corneal scraping (DNeasy® plant mini kit, Qiagen, Cat No./ID: 69104, Germany) and was subjected to 18S rDNA based PCR using earlier described JDP 1 and 2 primers specific to the genus Acanthamoeba.[4]Acanthamoeba DNA was detected. After 48 hours of incubation, the non-nutrient agar plate with E. coli overlay showed growth of trophozoites and cysts resembling Acanthamoeba. The isolate was made axenic and in order to determine species, previously described primers for free-living amoeba were used for 18S rDNA based sequencing.[6] Chromatogram analysis, as well as the sequences obtained using forward and reverse primers targeting 18S rDNA were assembled using DNA star laser gene SeqManpro 7.1 software. BLAST algorithm with default parameters were used to identify closest neighbors in NCBI nucleotide sequence database which confirmed the organism to be Acanthamoeba jacobsi (99% homology) with the query coverage of assembled sequence being 100 and the “e – value” as 0.0.

Clustal W multiple alignment was performed through BioEdit software to align the sequences of the clinical isolate and the reference strains of closely related species. The phylogenetic relationship of the aligned sequences was determined using neighbor joining algorithm of MEGA software version 6.06 with 1000 boot strap replications [Figure 3]. The sequence was deposited in the NCBI data base under accession number MK673930.
Figure 3: Neighbor-joining distance tree based on partial 18S rDNA sequences showing the clustering of clinical isolate L-480/18 with its closest relative Acanthamoeba jacobsi (shown in bold). Bootstra p values (1,000 replicates) of 50% are given at the nodes. Balamuthiamandrillaris was used as an outgroup. The 18S rDNA sequences of all the type strains were retrieved from NCBI database. Scale bar represents the number of substitutions per nucleotide position

Click here to view


At 3 weeks, the patient showed clinical improvement with decrease in photophobia and peripheral scarring and vascularization of the ulcer [Figure 1c]. The frequency of eye drops chlorhexidine (0.02%) was reduced to 4 times a day and eye drops PHMB (0.02%) was prescribed 8 times a day. By 8 weeks, the lesion resolved completely with scarring with vision of 20/60 which further improved on contact lens trial to 20/30 [Figure 1d]. The patient was continued on eye drops PHMB (0.02%) 4 times a day and tear supplements for the next 4 weeks.


  Discussion Top


Acanthamoeba are ubiquitous microorganisms which cause a variety of systemic infections as well as keratitis.[7] FromIndia, Sharma et al. published the first case report of Acanthamoeba keratitis.[8],[9] Several reports and updates on Acanthamoeba keratitis have been published from all over the world over time.[10],[11],[12] In developing countries such as India, trauma is the most common predisposing factor as opposed to contact lens wear reported in western literature.[7] In the life cycle of Acanthamoeba, trophozoites are sensitive to most available chemotherapeutic agents. However, presence of Acanthamoeba cysts in the body leads to persistent infection, against which very few agents are effective.[13] Biguanides and diamidines have been reported to have the best cysticidal activity.[14],[15] Based on vastly reported literature, topical polyhexamethylene biguanide (PHMB 0.02%) remains the primary therapy.[16] Adjuvant therapy with chlorhexidine 0.02% has shown enhanced resolution of Acanthamoeba keratitis.[15],[17] This case did not show improvement with PHMB monotherapy; however, when chlorhexidine was added as adjuvant therapy, the keratitis resolved. This emphasizes the treatment of Acanthamoeba keratitis with combination therapy as opposed to monotherapy.

With the advent of effective antiamoebic therapy surgical intervention for Acanthamoeba keratitis has been on a decline and reserved only for cases threatening limbus, perforations, and those worsening on medical therapy.[12] Moreover graft failure and recurrence of infection in grafts are known complications after surgery.[18] This patient was successfully managed on medical therapy alone, thus circumventing the need for a keratoplasty, which in children is always a challenge.

Several species of Acanthamoeba have been identified which are broadly designated in three groups based on their cyst morphology. However, on the basis of their nuclear gene (18S rDNA) sequences, Acanthamoeba species are recognized as at least 20 genotypes (T1-T20).[19] Short (<500 bp) 18S rDNA fragments have been able to identify the different strains. The specificgenotype T15, corresponds to Acanthamoeba jacobsi. While studies from India and worldwide report T4 as the most prevalent genotype in AK patients, keratitis due to T15 strain, to the best of our knowledge has not been reported before.[20],[21],[22]

Behera et al. from India, in their phylogenetic analysis reported 16 of the 20 isolates to be of T4, two of genotype T10 and the remaining two isolates of unassigned genotypes.[20] T4 was also the most commonly isolated strain in studies by Derda et al., Parischa et al., and Ertabaklar et al.[21],[22],[23] Additionally, the cysts of Acanthamoeba jacobsi bear a striking resemblance to the cysts of Dictyostelium polycephalum that has been reported by Reddy et al.[5] There are very few reported cases of the same and the management of such cases remains a dilemma.

Prognosis of Acanthamoeba keratitis depends on correct timely diagnosis and appropriate treatment. Advances in microbiological techniques further help in identification of the organism as well as the species. In this case, gene sequencing not only helped us to distinguish Acanthamoeba species from Dictyostelium species but also helped to identify the specific genotype (T15).

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Dart JK, Saw VP, Kilvington S. Acanthamoeba keratitis: Diagnosis and treatment update 2009. Am J Ophthalmol 2009;148:487-9900.  Back to cited text no. 1
    
2.
Jones DB, Visvesvara GS, Robinson NM. Acanthamoeba polyphaga keratitis and Acenthamoeba uveitis associated with fatal meningoencephalitis. Trans Ophthalmol Soc U K 1975;95:221-32.  Back to cited text no. 2
    
3.
Seal DV. Acanthamoeba keratitis update-incidence, molecular epidemiology and new drugs for treatment. Eye 2003;17:893-905.  Back to cited text no. 3
    
4.
Schroeder JM, Booton GC, Hay J, Niszl IA, Seal DV, Markus MB, et al. Use of subgenic 18S ribosomal DNA PCR and sequencing for genus and genotype identification of acanthamoebae from humans with keratitis and from sewage sludge. J Clin Microbiol 2001;39:1903-11.  Back to cited text no. 4
    
5.
Reddy AK, Balne PK, Garg P, Sangwan VS, Das M, Krishna PV, et al. Dictyostelium polycephalum Infection of Human Cornea. Emerg Infect Dis 2010;16:1644-5.  Back to cited text no. 5
    
6.
Tsvetkova N, Schild M, Panaiotov S, Mintcheva RK, Gottstein B, Walochnik J, et al. The identification of free living environmental isolates of amoebae from Bulgaria. Parasitol Res 2004;92:405-13.  Back to cited text no. 6
    
7.
Garg P, Kalra P, Joseph J. Non-contact lens related Acanthamoeba keratitis. Indian J Ophthalmol 2017;65:1079-86.  Back to cited text no. 7
[PUBMED]  [Full text]  
8.
Sharma S, Srinivasan M, George C. Acanthamoeba keratitis in non-contact lens wearers. Arch Ophthalmol 1990;108:676-8.  Back to cited text no. 8
    
9.
Sharma S, Srinivasan M, George C. Diagnosis of Acanthamoeba keratitis – A report of four cases and review of literature. Indian J Ophthalmol 1990;38:50-6.  Back to cited text no. 9
[PUBMED]  [Full text]  
10.
Tanhehco T, Colby K. The clinical experience of Acanthamoeba keratitis at a tertiary care eye hospital. Cornea 2010;29:1005-10.  Back to cited text no. 10
    
11.
Qian Y, Meisler DM, Langston RH, Jeng BH. Clinical experience with Acanthamoeba keratitis at the Cole Eye Institute, 1999-2008. Cornea 2010;29:1016-21.  Back to cited text no. 11
    
12.
Gopinathan U, Sharma S, Garg P, Rao GN. Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: Experience of over a decade. Indian J Ophthalmol 2009;57:273-9.  Back to cited text no. 12
[PUBMED]  [Full text]  
13.
Schuster FL, Visvesvara GS. Opportunistic amoebae: Challenges in prophylaxis and treatment. Drug Resist Updat 2004;7:41-51.  Back to cited text no. 13
    
14.
Duguid IG, Dart JK, Morlet N, Allan BD, Matheson M, Ficker L, et al. Outcome of Acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. Ophthalmology 1997;104:1587-92.  Back to cited text no. 14
    
15.
Seal D, Hay J, Kirkness C, Morrell A, Booth A, Tullo A, et al. Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine. Eye (Lond) 1996;10:413-21.  Back to cited text no. 15
    
16.
Larkin DF, Kilvington S, Dart JK. Treatment of Acanthamoeba keratitis with poly hexamethylene biguanide. Ophthalmology 1992;99:185-91.  Back to cited text no. 16
    
17.
Sharma S, Garg P, Rao GN. Patient Characteristics, diagnosis and treatment of non-contact lens related Acanthamoeba keratitis. Br J Ophthalmol 2000;84:1103-8.  Back to cited text no. 17
    
18.
Kitzmann AS, Goins KM, Sutphin JE, Wagoner MD. Keratoplasty for treatment of Acanthamoeba keratitis. Ophthalmology 2009;116:864-9.  Back to cited text no. 18
    
19.
Corsaro D, Köhsler M, Montalbano Di Filippo M, Venditti D, Monno R, Di Cave D, et al. Update on Acanthamoeba jacobsi genotype T15, including full-length 18S rDNA molecular phylogeny. Parasitol Res 2017;116:1273-84.  Back to cited text no. 19
    
20.
Behera HS, Panda A, Satpathy G, Bandivadekar P, Vanathi M, Agarwal T, et al. Genotyping of Acanthamoeba spp. and characterization of the prevalent T4 type along with T10 and unassigned genotypes from amoebic keratitis patients in India. J Med Microbiol 2016;65:370-6.  Back to cited text no. 20
    
21.
Derda M, Solarczyk P, Cholewiński M, Hadaś E. Genotypic characterization of amoeba isolated from Acanthamoeba keratitis in Poland. Parasitol Res 2015;114:1233-7.  Back to cited text no. 21
    
22.
Ertabaklar H, Türk M, Dayanir V, Ertuǧ S, Walochnik J. Acanthamoeba keratitis due to Acanthamoeba genotype T4 in a non-contact-lens wearer in Turkey. Parasitol Res 2007;100:241.  Back to cited text no. 22
    
23.
Pasricha G, Sharma S, Garg P, Aggarwal RK. Use of 18S rRNA gene-based PCR assay for diagnosis of Acanthameobea keratitis in non-contact lens wearers in India. J Clin Microbiol 2003;41:3206-11.  Back to cited text no. 23
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]



 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
Abstract
Case Report
Discussion
References
Article Figures

 Article Access Statistics
    Viewed156    
    Printed0    
    Emailed0    
    PDF Downloaded55    
    Comments [Add]    

Recommend this journal